MedTrace Logo

N Acetyl Cysteine for Cystinosis Patients

NCT01614431 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2012-06-20

No results posted yet for this study

Summary

This study intends to verify the interference of N acetyl cysteine in the progression of chronic kidney disease in patients with Nephropathic Cystinosis.

Conditions

  • Renal Disease
  • Cystinosis

Interventions

DRUG

N acetyl cysteine

N acetyl cysteine to cystinosis patients with CKD stages 1 to 4

DRUG

N acetyl cysteine

N acetyl cysteine for cystinosis patients CKD stages 1 to 4

Sponsors & Collaborators

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

    collaborator OTHER_GOV

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Maria Helena Vaisbich, Doctor · University of Sao Paulo

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-01-31
Completion
2012-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01614431 on ClinicalTrials.gov